Mustbio signs a CDO contract with Protium to develop new bispecific antibody (Biospectator, 2023.01.05) Date2023-01-09 View624 http://www.biospectator.com/view/news_view.php?varAtcId=18033 Prev Solid PoC data required to attract biotech investment (Hitnews, 2023.01.02) Next [Notice] New stock issuance (2023.02.27) back to list
